With the goal to become a top 3 pharma company in China, Novartis has been busy tapping into the expertise of local drugmakers. In its latest collaboration, Novartis has signed a strategic ...

In this article, we are going to take a look at where ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) stands against other Friday’s top performers. The stock market finished the trading week in the ...

Pharmaceutical manufacturers, such as Pfizer, Johnson & Johnson, and Novartis, are driving digital transformation to enhance production efficiency and maintain compliance—an essential factor in ...

The pool of attendees typically includes leading medical researchers, pharmaceutical company executives and patient advocates. The annual megaconference is known for attracting a diverse audience of ...

Pharmaceutical maker Regeneron announced Monday it will buy genetic testing company 23andMe for $256 million following a bankruptcy auction. Regeneron said it will acquire 23andMe’s genomics ...

There's little doubt these pharmaceutical companies' costs will soon be rising at least a little. The tariff war the U.S. is waging against most of the world stabilized somewhat earlier this month.

Regeneron Pharmaceuticals has acquired 23andMe – and the genetic data for 15 million customers along with it. Credit: Tiffany Hagler-Geard/Bloomberg via Getty Images 23andMe had all the signs of ...

3 Summer "Power Patterns" Are About to Trigger (One With 90% Win Rate) - Get The Details Now Rocket Pharmaceuticals Inc RCKT announced an update Tuesday related to RP-A501, its investigational ...

Regeneron Pharmaceuticals on Monday announced it is buying 23andMe out of bankruptcy for $256 million – taking with it the company’s extensive trove of genetic samples and data. It will ...

Fresh off taking the top spot in an annual survey of how patient groups around the world view major drugmakers, ViiV Healthcare has clinched the No. 1 slot in a U.S.-specific version of the survey ...

May 27 (Reuters) - The U.S. FDA has paused Rocket Pharmaceuticals' (RCKT.O), opens new tab mid-stage gene therapy trial after a patient died from serious complications, the drug developer said on ...

You can reach Jason on Signal at JasonMast.05. Rocket Pharmaceuticals said Tuesday that a patient had died in a trial studying its experimental gene therapy for a rare heart condition called Danon ...